SRC
Shufro Rose & Co Portfolio holdings
AUM
$1.24B
This Quarter Return
+10.61%
1 Year Return
+9.16%
3 Year Return
+41.09%
5 Year Return
+79.68%
10 Year Return
+163.77%
AUM
$947M
AUM Growth
+$947M
(+8.4%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
31.65%
Holding
277
New
24
Increased
72
Reduced
85
Closed
13
Top Buys
| 1 |
COL
Rockwell Collins
COL
|
$10.8M |
| 2 |
LTM
LIFE TIME FITNESS INC
LTM
|
$9.95M |
| 3 |
Valmont Industries
VMI
|
$8.16M |
| 4 |
Darling Ingredients
DAR
|
$6.12M |
| 5 |
Vishay Precision Group
VPG
|
$1.58M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$16.4M |
| 2 |
Crocs
CROX
|
$6.91M |
| 3 |
Exelon
EXC
|
$6.61M |
| 4 |
Thermo Fisher Scientific
TMO
|
$6.3M |
| 5 |
Avery Dennison
AVY
|
$5.88M |
Sector Composition
| 1 | Technology | 21.01% |
| 2 | Industrials | 17.52% |
| 3 | Healthcare | 12.8% |
| 4 | Consumer Discretionary | 12.43% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPT
151
Putnam Premier Income Trust
PPT
$353M
| $606K | 0.06% | 111,500 +3,500 | +3% | +$19K |
|
152
Coeur Mining
CDE
$8.45B
| $604K | 0.06% | 55,675 +17,200 | +45% | +$187K |
|
153
Elevance Health
ELV
$71.8B
| $591K | 0.06% | 6,400 | – | – |
|
154
SPDR S&P Biotech ETF
XBI
$5.07B
| $585K | 0.06% | 4,500 -700 | -13% | -$91K |
|
155
Old Republic International
ORI
$9.93B
| $569K | 0.06% | 32,975 -2,875 | -8% | -$49.6K |
|
156
RTX Corp
RTX
$212B
| $569K | 0.06% | 5,000 +2,000 | +67% | +$228K |
|
|
CRR
157
DELISTED
Carbo Ceramics Inc.
CRR
| $568K | 0.06% | 4,875 -300 | -6% | -$35K |
|
|
158
Crocs
CROX
$4.76B
| $557K | 0.06% | 35,025 -434,350 | -93% | -$6.91M |
|
|
ANDV
159
DELISTED
Andeavor
ANDV
| $555K | 0.06% | 9,500 -300 | -3% | -$17.5K |
|
|
MJN
160
DELISTED
Mead Johnson Nutrition Company
MJN
| $552K | 0.06% | 6,600 | – | – |
|
161
Skechers
SKX
$9.48B
| $543K | 0.06% | 16,400 -8,185 | -33% | -$271K |
|
|
ORBK
162
DELISTED
Orbotech Ltd
ORBK
| $505K | 0.05% | 37,400 +15,000 | +67% | +$203K |
|
163
Procter & Gamble
PG
$368B
| $492K | 0.05% | +6,045 | New | +$492K |
|
|
PFL
164
PIMCO Income Strategy Fund
PFL
$381M
| $474K | 0.05% | 41,950 +500 | +1% | +$5.65K |
|
165
Philip Morris
PM
$260B
| $474K | 0.05% | +5,450 | New | +$474K |
|
166
Mercer International
MERC
$223M
| $473K | 0.05% | 47,500 -1,000 | -2% | -$9.96K |
|
167
Sysco
SYY
$38.5B
| $469K | 0.05% | 13,000 -3,900 | -23% | -$141K |
|
|
VE
168
DELISTED
VEOLIA ENVIRONNEMENT
VE
| $468K | 0.05% | 28,650 -400 | -1% | -$6.53K |
|
|
WBA
169
DELISTED
Walgreens Boots Alliance
WBA
| $459K | 0.05% | 8,000 | – | – |
|
170
Invesco Trust for Investment Grade New York Municipals
VTN
$148M
| $444K | 0.05% | 34,000 +2,500 | +8% | +$32.6K |
|
171
Schlumberger
SLB
$55B
| $438K | 0.05% | 4,870 | – | – |
|
172
Union Pacific
UNP
$133B
| $436K | 0.05% | 2,600 +1,000 | +63% | +$168K |
|
173
Opko Health
OPK
$1.1B
| $435K | 0.05% | 51,600 +28,800 | +126% | +$243K |
|
174
Rand Capital
RAND
$47.9M
| $416K | 0.04% | 133,300 +5,334 | +4% | +$16.6K |
|
175
Bank of New York Mellon
BK
$74.5B
| $412K | 0.04% | 11,800 -5,500 | -32% | -$192K |
|